Skip to main content

Research Alliance Corp III

RACC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002118032

No open-market purchases or sales by Research Alliance Corp III insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $79.6M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Research Alliance Corp III changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of RACC: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders023+23
Shares07.43M+7.43M
Value$0$79.6M+$79.6M

New holders (23)

Institutions that held Research Alliance Corp III at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to RACC in Q2 2026
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC750,000$8.03M0.12%
ADAR1 Capital Management, LLC650,000$6.96M0.33%
BVF Inc500,000$5.35M0.14%
Balyasny Asset Management LLC500,000$5.35M0.01%
Commodore Capital LP500,000$5.35M0.32%
TCG Crossover Management, LLC500,000$5.35M0.13%
Spruce Street Capital LP500,000$5.35M1.05%
Trails Edge Capital Partners, LP500,000$5.35M0.85%
Jupiter Topco LLC400,000$4.37M0.00%
Braidwell LP400,000$4.28M0.16%
Cormorant Asset Management, LP370,000$3.96M0.20%
Affinity Asset Advisors, LLC370,000$3.96M0.19%
Silverarc Capital Management, LLC360,000$3.85M0.43%
VR Adviser, LLC300,000$3.21M0.10%
Foresite Capital Management VI LLC300,000$3.21M0.50%
J. Goldman & Co LP177,531$1.90M0.07%
Toronto Dominion Bank146,811$1.57M0.00%
Logos Global Management LP100,000$1.07M0.05%
Aristeia Capital LLC50,000$535.0K0.01%
Two Sigma Investments, LP33,912$362.9K0.00%
Lineage Point Capital LP23,302$249.3K0.05%
UBS Group AG16$1710.00%
Morgan Stanley7$750.00%

Sold out (0)

Institutions that held Research Alliance Corp III at the end of Q1 2026 and filed for Q2 2026 without it.

None.